Mice used to study ulcerative colitis 
  U.S. experiments with mice have identified an immune deficiency as the likely cause of ulcerative colitis -- a severe inflammatory disease of the colon. Harvard School of Public Health scientists also determined that once the disease was established in mice, it could be passed from mother to offspring and even between adult animals.The researchers said they linked ulcerative colitis in mice to a deficiency of a molecular peacekeeper in the immune systtem.

DRUG HELPS IN TREATMENT OF DIGESTIVE TRACT DISORDER 
  An anti-rejection drug used for organ transplant recipients also appears effective in treating some people with a debilitating digestive tract disorder, scientists said Wednesday.A study involving 20 patients with severe ulcerative colitis found two weeks of treatment with intravenous doses of cyclosporine reduced pain, cramping and abdominal tenderness and lessened the frequency of diarrhea and other symptoms.

Crohn's sufferers can find support 
  Even though about 1.4 million Americans suffer from Crohn's disease and the related condition ulcerative colitis, patients often keep the illnesses hidden from all except their doctors and closest family members and friends.With persistent diarrhea, related bleeding and crampy, abdominal pain, the embarrassment for many is socially debilitating.

Pluristem Demonstrates the Potential of Its PLX Cells to Treat Crohn's Disease and Ulcerative Colitis 
  Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company’s PLacental eXpanded (PLX) cells have demonstrated in vivo efficacy in the treatment of Crohn’s Disease and Ulcerative Colitis, collectively termed Inflammatory Bowel Disease (IBD)

Although Remicade and Humira Are Being Increasingly Prescribed for Crohn's Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies,  Nearly One-Third of Surveyed Managed Care Organizations Levy Coinsurance Charges and Other Protocols on Remicade and Humira, According to a New Report from Decision Resources 
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although gastroenterologists are increasingly prescribing Centocor/Schering-Plough/Mitsubishi Tanabe's Remicade and Abbott/Eisai's Humira for the treatment of Crohn's disease and ulcerative colitis, a high proportion of managed care organizations (MCOs) subject both drugs to multiple cost-control.
 
 
 

There are also herbal medicines which can very effectively treat colitis & ulcerative colitis. Boswellia is an Ayurvedic  (Indian traditional medicine) herb, used as a natural alternative to drugs. Many studies have found that the effectiveness of Boswellia is similar and even superior to sulfasalazine based prescription drugs. (Source Wikipedia: http://en.wikipedia.org/wiki/Ulcerative_colitis. 

We recommend taking a 4 months course of our Boswellia Serrata Extract.
 
 

Total of 4 bottles-  of Boswellia - 4 Months course - Taken 2 capusles twice a day.
 
 

There are NO ADDITIONAL CHARGES. Packing & Shipping is absolutely FREE. We will deliver direct to your door to reach within 12 days from the date of ordering. A signature will be required at the time of delivery. You can give us your daytime work address or Post Box address if no one will be present at home to receive the shipment during daytime. 
 

Please use the form below to mail us for any information. We will revert back within 10 hours .